Purchase Order 75N98F19P00007

<p>The National Institute of Nursing Research awarded a purchase order to Illumina, Inc. for $20,269.44 on September 21, 2017, with an ultimate completion date of October 31, 2017. Place of performance is San Diego, California. The order is firm fixed price with no set-aside applied. The purchase order procures sequencing instruments, reagents, consumables, or bioinformatics software consistent with Illumina's core product portfolio in DNA and RNA sequencing technologies.</p>

<p>The National Institute of Nursing Research awarded a purchase order to Illumina, Inc. for $13,512.96 on April 2, 2018, with completion scheduled for May 2, 2018. Work is performed in San Diego, California. The order is firm fixed price with no set-aside category applied. The source does not specify the particular equipment, reagents, consumables, or services procured under this order.</p>

<p>The National Institute of Nursing Research awarded a purchase order to Illumina, Inc. for $13,512.96 on June 29, 2018, with an ultimate completion date of July 27, 2018. Work is performed in San Diego, California. The order covers DNA and RNA sequencing instruments, reagents, consumables, or bioinformatics software. No set-aside was used.</p>

<p>The National Institute of Nursing Research awarded a purchase order to Illumina, Inc. for $13,512.96 on May 3, 2018, with an ultimate completion date of June 4, 2018. Performance takes place in San Diego, California. The order procures sequencing reagents, consumables, or related bioinformatics products. No set-aside applies.</p>

<p>The National Institute of Nursing Research awarded a purchase order to Illumina, Inc. for $13,512.96 on August 10, 2017, with completion by September 29, 2017. No set-aside applied. Place of performance is San Diego, California. The order procures sequencing reagents, consumables, or related bioinformatics support—Illumina's core product line—on a firm fixed price basis.</p>

<p>The National Institute of Neurological Disorders and Stroke awarded a purchase order to Illumina, Inc. valued at $16,189.27 on July 31, 2018, with ultimate completion on July 30, 2019. The order is firm fixed price with no set-aside. Work is performed in San Diego, California. The purchase order procures sequencing instruments, reagents, consumables, or bioinformatics software—Illumina's core offerings to federal health and research agencies.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $17,735.76 on December 21, 2018, with completion by December 25, 2019. The order is a firm fixed price acquisition with no set-aside. Work is performed at Bethesda, Maryland. The purchase order procures DNA and RNA sequencing instruments, reagents, consumables, or bioinformatics software—Illumina's core product lines serving federal health and research agencies.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Illumina, Inc. for $16,285.00 on November 17, 2017, with an ultimate completion date of November 17, 2018. Place of performance is San Diego, California. The order covers DNA and RNA sequencing instruments, reagents, consumables, or bioinformatics software. No set-aside category was used.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. valued at $19,792.44 on August 15, 2018, for DNA and RNA sequencing instruments, reagents, consumables, and bioinformatics software. Performance is at North Bethesda, Maryland, with an ultimate completion date of September 14, 2018. The order carries firm fixed price terms and no set-aside designation.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $13,250.00 on October 29, 2019, with an ultimate completion date of October 28, 2020. Work is performed in San Diego, California. The order is a firm fixed-price purchase for sequencing reagents, consumables, or related instrumentation—Illumina's core product line sold to NIH institutes and other federal research agencies. No set-aside applies.</p>